Although we did not analyze in the current study whether these two pathways are involved in regulating the GM-CSF-induced cell stemness and drug resistance, our high-throughput RNA sequencing data analyses suggested activation of PI3k/Akt signaling after GM-CSF treatment in gastric cancer. This evidence concerns the gene CSF2 and gastric cancer.